Taku Fujimura

81PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersMedical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Aug 03, 2026
Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.

|Jun 09, 2026
Hypopigmented Mycosis Fungoides With Childhood-Onset and Middle-Aged Onset: Two Case Reports Focusing on the Cutaneous Immune Microenvironment.

|Jan 08, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Jan 07, 2026
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders.

T Kimura, N Tanaka, T Maekawa

|Dec 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Oct 28, 2025
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.

Emi Yamazaki, Taku Fujimura, Yumi Kambayashi

Pageof 14

Frequent Collaborators

17 joint publications

Yumi Kambayashi

16 joint publications

Yoshihide Asano

10 joint publications

Yasuhiro Fujisawa

10 joint publications

Yusuke Muto